Methylhexanamine
| 1,3-DMAA | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 115.22 g/mol [1] |
| Appearance | Liquid [1] |
| Odor | Amine odor [1] |
| Density | 0.7655 g/cu cm at 20 °C [1] |
| Boiling point | 132.5 °C [1] |
| Solubility | Slightly soluble in water; very soluble in ethanol, ether, chloroform and dilute acid [1] |
| Predicted LogP | 1.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C7H17N |
| IUPAC name | 4-methylhexan-2-amine |
| SMILES | CCC(C)CC(C)N |
| InChI | InChI=1S/C7H17N/c1-4-6(2)5-7(3)8/h6-7H,4-5,8H2,1-3H3 |
| InChIKey | YAHRDLICUYEDAU-UHFFFAOYSA-N |
| CAS number | 105-41-9 |
| UNII | X49C572YQO |
| PubChem CID | 7753 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | ~8.5 hours |
| Routes of administration | Nasal spray, oral |
| Toxicity [] | |
|---|---|
| LD50 | Mice: - i.p.: 185 mg/kg [1] |
Methylhexanamine (also known as 1,3-Dimethylpentylamine, Methylhexaneamine, Forthane, 2-Amino-4-methylhexane, Forthan, 4-Methyl-2-hexanamine, 4-Methyl-2-hexylamine, Dimethylamylamine, Geranamine or floradrene) is a stimulant substance of the amine class.
Chemistry
Stereochemistry []
Methylhexanamine is a racemic mixture of the diastereomers.
Druglikeness
Lipinski's rule of five
Methylhexanamine matches Lipinski's rule of five.Pharmacology
Mechanism of action []
Physiology studies of the compound in the 1940s and 1950s demonstrated its sympathomimetic physiological effects that mimic the action of epinephrine with both peripheral sympathetic neuron and central nervous system effects. These include increases in blood pressure due to the constriction of peripheral blood vessels, increased heart rate due to cardiac stimulation and increased blood sugar levels. [1]
Subjective effects []
Legal status []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 7753, Methylhexanamine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/7753
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Methylhexanamine. UNII: X49C572YQO. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/X49C572YQO
Federal Register of Legislation. Australian Government. 2024-09-30.
RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
DMAA: A prohibited stimulant. United States Department of Defense: Operation Supplement Safety. October 12, 2022. https://www.opss.org/article/dmaa-prohibited-stimulant
DMAA in Products Marketed as Dietary Supplements. United States Food and Drug Administration. February 22, 2023. https://www.fda.gov/food/information-select-dietary-supplement-ingredients-and-other-substances/dmaa-products-marketed-dietary-supplements?ref=smartchoicelist.com
United States v. Hi-Tech Pharmaceuticals, Inc., No. 17-13376 (11th Cir. 2019). Justia Law. August 30, 2019. https://law.justia.com/cases/federal/appellate-courts/ca11/17-13376/17-13376-2019-08-30.html
Meyer H. E. R. Squibb & Sons, inc. et al.; Withdrawal of Approval of New Drug Applications. Federal Register. November 9, 1983. https://www.govinfo.gov/content/pkg/FR-1983-11-09/pdf/FR-1983-11-09.pdf
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 03:07:19 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 03:07:15 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 03:07:15 |
| gsrs | ok | 2026-11-20 03:07:15 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0244169) | 2026-11-20 03:07:15 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 03:07:19 |
| pubchem | ok | 2026-11-20 03:07:13 |
| missing (no r/tripreports posts mention it) | 2026-11-20 03:07:15 | |
| sider | missing (not in SIDER) | 2026-11-20 03:07:15 |
| structure | ok | 2026-11-20 03:07:15 |
| wikipedia | ok | 2026-11-20 03:07:15 |